July/August 2015

 

In this Issue

The Complex World of Therapeutics

New concepts in the nonsurgical treatment of retinal diseases.

  • Issue

  • Insert

  • Supplement

  • Supplement

 
View the E-Dition

The Importance of Being Current

By Allen C. Ho, MD, Chief Medical Editor; and Robert L. Avery, MD, Associate Medical Editor

NEWS

News

BUSINESS OF RETINA

Pennsylvania Avenue Updates

PQRS in the Retina Practice

What it is, why it is important, and what it means for physicians.

By Paul Gallogly, MD
Innovations in Retina

Staying Current With Apps

Retina specialists are finding that apps are not just for music and games anymore.

By Aron Shapiro
Fellows' Focus

Meeting Mindfulness

A quick guide to attending educational meetings and conferences as a vitreoretinal surgical fellow.

By Jayanth Sridhar, MD; Yoshihiro Yonekawa, MD; and Daniel Chao, MD, PhD
Coding for Retina

Comparative Billing Reports: A Case Study

A closer look at the validity of the auditing parameters pertaining to general ophthalmological services—the eye codes—and of the findings as pertains to retina practices that use eye codes exclusively.

By Riva Lee Asbell

RETINA SURGERY

Retina Pearls

Step-by-Step Guide to Retinal Implant Surgery

Surgical pearls for this complex implantation procedure.

By Lisa C. Olmos de Koo, MD, MBA; and Ninel Z. Gregori, MD
Global Perspectives

Macular Buckling for Retinal Detachment in Highly Myopic Eyes With Macular Hole

Use of a modified macular buckle improved precision and allowed optimal positioning.

By Matteo Forlini, MD; Małgorzata Szkaradek, MD; Robert Rejdak, MD, PhD; Adriana Bratu, MD; Paolo Rossini, MD; Cesare Forlini, MD; and Gian Maria Cavallini, MD
Feature Story

Laser Use and the Future of Retina Practice

Recent findings support the combination of pharmacologic and laser therapies for retinal diseases.

By Anat Loewenstein, MD
Feature Story

Endoscopy in Pediatric Vitreoretinal Surgery

Although not a replacement for the microscope, the endoscope has an important place in retina surgery.

By S. Chien Wong, MD, FRCSEd (Ophth)

TECHNOLOGY

A New Self-Testing System for Patients With AMD or DME

Changing treatment patterns often dictate the need for a change in disease detection.

By Raj K. Maturi, MD

IMAGING

SD-OCT Imaging in Eyes Implanted With a Miniature Telescope

Overcoming imaging challenges in eyes of AMD patients implanted with a telescope can result in high-quality images.

By Anna Pappas, BS, COA; Melanie J. Fortin, BS, COA; and Brian C. Joondeph, MD, MPS

What’s Up With OCTA?

By understanding the mechanisms of a new imaging tool, retina specialists may further appreciate its potential.

By Talisa E. de Carlo, BA; Gregory D. Lee, MD; David R. Lally, MD; and Jay S. Duker, MD

SPECIAL FOCUS: OCULAR ONCOLOGY

Treating Uveal Melanoma: Past, Present, and Future

Genomic analysis can help to personalize treatment and lead to better outcomes.

By Aaron S. Gold, OD; Victor M. Villegas, MD; Andrea Wildner, CRA; Jennifer Thomson, CRA; Fiona J. Ehlies, BSc, CDOS; and Timothy G. Murray, MD, MBA, FACS

Retinal Hemangiomas: Understanding Clinical Features, Imaging, and Therapies

Several different vascular tumors can occur in the retina, each with its own features and findings.

By Carol L. Shields, MD; Alexzandra Douglass, BS; Timothy Higgins, BS; Wasim A. Samara, MD; and Jerry A. Shields, MD

Personalized Medicine in Ocular Oncology

The options for focal treatment of retinoblastoma are growing. Here is a rundown of the latest options and what the latest studies reveal.

By Victor M. Villegas, MD; Aaron S. Gold, OD; Andrea Wildner, CRA; Jennifer Thomson, CRA; Fiona J. Ehlies, BSc, CDOS; and Timothy G. Murray, MD, MBA, FACS

COVER STORIES

Individualizing Therapy for DME

Disease features as well as individual patient needs and preferences should drive treatment choices.

By Antonio Capone Jr, MD

Examining the Systemic Safety of Anti-VEGF Agents

Although use of anti-VEGF agents seems safe in the general population, systemic safety concerns remain in at-risk patients.

By Karen Roman, Editor-in-Chief

A Dual-Mechanism Drug for Vitreoretinal Diseases

With two distinct mechanisms of action, a new anti-integrin drug may be able to treat multiple targets across a range of conditions.

By Baruch D. Kuppermann, MD, PhD

Incorporating New Technologies Into Practice: The Big Picture

When it comes to managing patients with diabetic macular edema, embracing new treatments requires planning.

By Szilárd Kiss, MD

Profile of a Potential Treatment for Geographic Atrophy

An in-depth look at a complement-targeted therapy.

By Karen Roman, Editor-in-Chief

Another Anti-VEGF Agent for Treatment of Neovascular AMD

If approved by the FDA, a new anti-VEGF agent could provide physicians with an alternative treatment for neovascular AMD.

By Xiaoxin Li, MD, PhD; Xiaoyan Ding, MD, PhD; and Peter K. Kaiser, MD

DEPARTMENTS

5Q With David Eichenbaum, MD

By David Eichenbaum, MD, is a Partner at Retina Vitreous Associates of Florida and an Affiliate Assistant Professor of Ophthalmology at the University of South Florida in Tampa, Florida.
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos
Editor-in-Chief
484-581-1880
skrzywonos@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.